Sign in

CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464348039
Phone
617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-17 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +9,333 $30.00 $280K 93,733
2024-06-17 Cohen Yuval Chief Executive Officer Sale 10b5-1 −9,333 $46.02 $430K 84,400
2024-06-17 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +1,770 $4.26 $8K 86,170
2024-06-17 Cohen Yuval Chief Executive Officer Sale 10b5-1 −1,770 $46.02 $81K 84,400
2024-06-17 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −9,333 11,667
2024-06-17 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −1,770 52,061
2024-06-14 Moran Sean F. Chief Financial Officer Option exercise 10b5-1 +1,567 $30.00 $47K 50,172
2024-06-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −1,567 $49.87 $78K 48,605
2024-06-14 Moran Sean F. Chief Financial Officer Option exercise 10b5-1 +7,788 $4.26 $33K 56,393
2024-06-14 Moran Sean F. Chief Financial Officer Sale 10b5-1 −7,788 $49.87 $388K 48,605
2024-06-14 Moran Sean F. Chief Financial Officer Option exercise · Options to purchase common stock 10b5-1 −1,567 1,958
2024-06-14 Moran Sean F. Chief Financial Officer Option exercise · Options to purchase common stock 10b5-1 −7,788 23,367
2024-06-14 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +16,830 $14.10 $237K 101,230
2024-06-14 Cohen Yuval Chief Executive Officer Sale 10b5-1 −16,830 $50.17 $844K 84,400
2024-06-14 Cohen Yuval Chief Executive Officer Option exercise 10b5-1 +12,487 $4.26 $53K 96,887
2024-06-14 Cohen Yuval Chief Executive Officer Sale 10b5-1 −12,487 $50.17 $626K 84,400
2024-06-14 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −16,830 32,827
2024-06-14 Cohen Yuval Chief Executive Officer Option exercise · Options to purchase common stock 10b5-1 −12,487 53,831
2024-06-14 HOLMER ALAN F Director Option exercise +1,667 $30.00 $50K 5,829
2024-06-14 HOLMER ALAN F Director Option exercise · Options to purchase common stock −1,667 0

Page 6 of 10 · 200 trades